Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors

By Johnson Neil   Shapiro Geoffrey I  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. : 1199-1212

Informa Healthcare

Access to resources Recommend Favorite

Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest

By Kim Won  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1311-1318

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and—resistant human ovarian cancer cells

By Marverti Gaetano   Ligabue Alessio   Montanari Monica   Guerrieri Davide   Cusumano Matteo   Pietro Maria   Troiano Leonarda   Vono Elena   Iotti Stefano   Farruggia Giovanna   Wolf Federica   Monti Maria   Frassineti Chiara  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 73-86

Springer Publishing Company

Access to resources Recommend Favorite

Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 884-895

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Damage Repair and Response Proteins as Targets for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 360-367

Bentham Science Publishers

Access to resources Recommend Favorite